Creative Medical Technology Holdings Inc (CELZ) Stock Price

2.27 ▲ +0.08 (+3.65%)
Open: 2.21 Vol: 63.48K Day's range: 2.19 - 2.31 May 20, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CELZ Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY NEUTRAL BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.26▼ 2.25▲ 2.26▼ 2.23▲ 2.27▼
MA10 2.26▼ 2.25▲ 2.25▲ 2.24▲ 2.18▲
MA20 2.24▲ 2.24▲ 2.26▼ 2.24▲ 2.07▲
MA50 2.25▲ 2.24▲ 2.26▼ 2.13▲ 2.59▼
MA100 2.23▲ 2.17▲ 2.13▲ 2.05▲ 2.81▼
MA200 2.09▲ 2.07▲ 2.08▲ 2.59▼ 3.95▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.002▲ 0.000▲ -0.002▼ -0.010▼ 0.071▲
RSI 51.101▲ 50.428▲ 50.184▲ 54.168▲ 49.803▼
STOCH 43.472     58.816     57.456     46.429     75.421    
WILL %R -55.000     -39.474     -39.474     -39.286     -28.767    
CCI -1.203     28.311     32.941     71.388     59.243    
Latest Filters Detected On CELZ
▲ RSI&VOL $CELZ RSI Cross Up and Volume Set Alert
RSI $CELZ RSI(14) Crossed Above 50 Set Alert
MA $CELZ Price Crossed Above MA(26) Set Alert
MA $CELZ Price Crossed Above MA(13) Set Alert
MA $CELZ Price Crossed Above MA(7) Set Alert
Creative Medical Technology Holdings Inc News
Creative Medical Tech Earnings Estimates, EPS & Revenue | NASDAQ:CELZ
Friday, May 08, 2026 03:23 PM
Creative Medical Tech (CELZ) is scheduled to report Q2 earnings on August 7, 2026. Analysts estimate EPS of $-0.37 and quarterly revenue of N/A. In the most recent quarter (Q1), Creative Medical Tech ...
Creative Medical Technology Holdings Inc.
Thursday, May 07, 2026 01:03 PM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell ...
Tuesday, April 28, 2026 06:26 AM
Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target Large, Underserved Osteoarthritis Market PHOENIX, April 28, 2026 (GLOBE NEWSWIRE) -- ...
CELZ historical stock data
date open high low close volume
20/05/26 2.21 2.31 2.19 2.27 63,483
19/05/26 2.1801 2.24 2.14 2.19 50,735
18/05/26 2.26 2.28 2.16 2.23 36,928
15/05/26 2.20 2.27 2.20 2.24 11,960
14/05/26 2.24 2.30 2.2007 2.24 38,307
13/05/26 2.33 2.33 2.20 2.21 31,824
12/05/26 2.28 2.2899 2.20 2.28 29,780
11/05/26 2.26 2.32 2.18 2.18 68,075
08/05/26 2.30 2.38 2.10 2.31 68,091
07/05/26 2.25 2.33 2.14 2.29 31,451
Quote Details
52wk Low:1.504
52wk High:6.25
Vol:63.48K
Avg Vol(3m):1M
1Y Chng:-5.19%
1M Chng:+11.27%
Add to Watch List
More Information
Index US Composite
Market Cap. 8.28M